| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b970743e25dae3f18be21b5ff83fffa2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_871d859822ee354b8191c1e6cf091515
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b3b8a24a2b0b012952f11842cf561bc5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_36ed0e65ff0722a811c6582ff1a7a7bd |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4402
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-655
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4402
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-635
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 |
| filingDate |
2018-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8539b62ec724901d3be5f3a26502386d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2a270f4722f5281a230d3a938339a61
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_82866893a89cf1403966885f14111259
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06755edcc889c5a6f2276e36af11a177 |
| publicationDate |
2020-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
BR-112020006796-A2 |
| titleOfInvention |
SULFASSALAZINE SALT COMPOSITIONS AND METHODS OF USE OF THE SAME |
| abstract |
The present invention provides sulfasalazine salt compositions. In some cases, the sulfasalazine salts have a crystalline form. The present crystalline sulfasalazine salts can provide a water-soluble form of the active compound that finds use in pharmaceutical compositions and therapeutic applications. The present sulfasalazine crystalline salts can provide increased solubility compared to the zwitterionic or acid free form of sulfasalazine. Pharmaceutical compositions are also provided including the present sulfasalazine salt compositions. Also provided are methods of treating a neurologically related disease such as refractory epilepsy using the present sulfasalazine salts and pharmaceutical compositions. |
| priorityDate |
2017-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |